
Pifer Pharmaceuticals Pvt Ltd
About Pifer Pharmaceuticals Pvt Ltd
Data last updated:
Pifer Pharmaceuticals Pvt Ltd is a private limited company based in Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 April 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB1994PTC014446. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.24 Lakh. It is led by directors Munish Salwan and Mithun Salwan.
Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 22 Rajauri Gardenbarewal Road Ludhiana, Punjab, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹48,000. For the same year it recorded a net profit of ₹1,596 (net margin 3.3%) and EBITDA of ₹1,950 (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 299% over three years.
As per MCA filings, the company has open charges of ₹41.12 Lakh and satisfied charges of ₹22 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address22 Rajauri Gardenbarewal Road Ludhiana, Punjab, India
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Pifer Pharmaceuticals Pvt Ltd FY 2024 filings available
Pifer Pharmaceuticals Pvt Ltd reported revenue of ₹48,000 for FY 2024.
Compounded Annual Growth Rate (CAGR) of Pifer Pharmaceuticals Pvt Ltd
Revenue has grown at a compounded annual rate (CAGR) of 299% over three years. EBITDA rose 108% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pifer Pharmaceuticals Pvt Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1,950 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1,596 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pifer Pharmaceuticals Pvt Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pifer Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pifer Pharmaceuticals Pvt Ltd
Pifer Pharmaceuticals Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Seasons Biologicals Private Limited | ₹49,010 (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Nectar Lifestyles Private Limited | ₹48,570 (FY 2018) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Aurex Laboratories Private Limited | ₹48,503 (FY 2025) | •••• | •••• | 5.0% | •••• | Hyderabad, Telangana, India |
| Hermes Pharmaceuticals Private Limited | ₹48,035 (FY 2025) | •••• | •••• | -39.0% | •••• | Medak, Telangana, India |
| Pifer Pharmaceuticals Pvt Ltd this company | ₹48,000 (FY 2024) | •••• | •••• | •••• | Punjab, India | |
| Stanfar Pharma Private Limited | ₹48,000 (FY 2024) | •••• | •••• | -50.0% | •••• | Bhiwadi, Rajasthan, India |
| Pills and Potion Pharmaceuticals Private Limited | ₹47,864 (FY 2023) | •••• | •••• | 15.0% | •••• | New Delhi, Delhi, India |
| Femera Life Sciences and Healthcare Private Limited | ₹47,832 (FY 2025) | •••• | •••• | -93.0% | •••• | Pune, Maharashtra, India |
| Medina Pharmaceuticals Private Limited | ₹47,570 (FY 2025) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Glowelshine Pharma Private Limited | ₹47,452 (FY 2021) | •••• | •••• | •••• | Patna, Bihar, India | |
| Dr. Remedies Pharmaceuticals Private Limited | ₹47,255 (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Pifer Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pifer Pharmaceuticals Pvt Ltd
Pifer Pharmaceuticals Pvt Ltd is audited by SAT PAL SHARMA & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SAT PAL SHARMA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Pifer Pharmaceuticals Pvt Ltd
Pifer Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Munish Salwan Also directs: Spanker Biotech Limited | Director | 18 Apr 1994 | 32 Years 5 Months | Current |
| Mithun Salwan Also directs: Spanker Biotech Limited | Director | 30 Nov 2003 | 22 Years 10 Months | Current |
Ownership and Shareholding of Pifer Pharmaceuticals Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pifer Pharmaceuticals Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2004 | Oriental Bank of Commerce | ₹5 Lakh | Open |
| 30 Dec 2004 | Oriental Bank of Commerce | ₹5 Lakh | Open |
| 20 May 2002 | Punjab National Bank | ₹10 Lakh | Open |
| 19 Apr 2002 | Punjab National Bank | ₹1.12 Lakh | Open |
| 09 Jul 2001 | Punjab National Bank | ₹7 Lakh | Open |
Total charge records: 9 View all charges
Legal Cases of Pifer Pharmaceuticals Pvt Ltd
Pifer Pharmaceuticals Pvt Ltd has 2 court cases on record: 2 filed against it. All cases are disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Ranbaxy Laboratories Ltd | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Pfizer Inc | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Pifer Pharmaceuticals Pvt Ltd
Employment history and EPFO contributions of people linked to Pifer Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pifer Pharmaceuticals Pvt Ltd
Pifer Pharmaceuticals Pvt Ltd has 4 board changes on record since 1994: 3 appointments and 1 cessation. The latest: Amarjit Rai Salwan ceased to be Director on 10 Aug 2009.
8 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Pifer Pharmaceuticals Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pifer Pharmaceuticals Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pifer Pharmaceuticals Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pifer Pharmaceuticals Pvt Ltd
Pifer Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pifer Pharmaceuticals Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pifer Pharmaceuticals Pvt Ltd
Pifer Pharmaceuticals is an active private limited company based in Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 April 1994 (32+ years old) and is registered under CIN U24232PB1994PTC014446.
Pifer Pharmaceuticals reported revenue of ₹48,000 for FY 2024.
Pifer Pharmaceuticals has 2 current directors:
- Munish Salwan - Director
- Mithun Salwan - Director
Pifer Pharmaceuticals reported a net profit of ₹1,596 (net margin 3.3%) and EBITDA of ₹1,950 (EBITDA margin 4.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pifer Pharmaceuticals is 299% over three years. CAGR is the steady yearly rate that links the first and the last year.
No. Pifer Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Pifer Pharmaceuticals is U24232PB1994PTC014446. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pifer Pharmaceuticals has 2 court cases on record: 2 filed against it.
Pifer Pharmaceuticals was incorporated on 18 April 1994, making it 32+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Pifer Pharmaceuticals by revenue are Seasons Biologicals Private Limited, Nectar Lifestyles Private Limited, Aurex Laboratories Private Limited, Hermes Pharmaceuticals Private Limited, Stanfar Pharma Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Amarjit Rai Salwan ceased to be Director on 10 Aug 2009. Amarjit Rai Salwan was appointed as Director on 12 Sep 2005. Mithun Salwan was appointed as Director on 30 Nov 2003. Pifer Pharmaceuticals has 4 board changes on record in total.